PTGES and urothelial carcinoma: These findings suggest that urothelial carcinomas that are at least T2 in nature show enhanced COX, prostaglandin synthase E, and thromboxane synthase pathways and repressed prostaglandin synthase D and prostacyclin synthase pathways.